Compliance With Once Daily Glaucoma Medication
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00333463 |
Recruitment Status
:
Completed
First Posted
: June 5, 2006
Last Update Posted
: November 18, 2016
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Compliance | Behavioral: Intervention |
Study Type : | Observational |
Estimated Enrollment : | 700 participants |
Time Perspective: | Retrospective |
Official Title: | Compliance With Once Daily Glaucoma Medication |
Study Start Date : | June 2006 |
Actual Primary Completion Date : | September 2007 |
Actual Study Completion Date : | September 2007 |

Group/Cohort | Intervention/treatment |
---|---|
Intervention group
The intervention group watched an educational video, reviewed current barriers to drop-taking and possible solutions with a study coordinator, received regular phone call reminders, and had audible and visible reminders activated on their DA devices.
|
Behavioral: Intervention
The intervention group watched an educational video, reviewed current barriers to drop-taking and possible solutions with a study coordinator, received regular phone call reminders, and had audible and visible reminders activated on their DA devices.
|
Non-Intervention Group
The control group was told to take drops as prescribed and received no additional intervention.
|

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | Child, Adult, Senior |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Probability Sample |
Inclusion Criteria:
- Primary open angle glaucoma or ocular hypertension patients
Exclusion Criteria:

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00333463
United States, Texas | |
Ft. Worth | |
Ft. Worth, Texas, United States, 76134 |
Study Director: | David Friedman, MD | Study Director |
Publications of Results:
Responsible Party: | Alcon Research |
ClinicalTrials.gov Identifier: | NCT00333463 History of Changes |
Other Study ID Numbers: |
CMS-06-03 |
First Posted: | June 5, 2006 Key Record Dates |
Last Update Posted: | November 18, 2016 |
Last Verified: | March 2010 |
Additional relevant MeSH terms:
Glaucoma Ocular Hypertension Eye Diseases |